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Abstract:
Haematopoietic stem and progenitor cells (HSPCs) develop through distinct waves at various anatomical sites during embryonic development.
The in vitro differentiation of human pluripotent stem cells (hPSCs) is able to recapitulate some of these processes but it has proven difficult to
generate functional haematopoietic stem cells (HSCs). To define the dynamics and heterogeneity of HSPCs that can be generated in vitro from
hPSCs, we exploited single cell RNA sequencing (scRNAseq) in combination with single cell protein expression analysis. Bioinformatics analyses
and functional validation defined the transcriptomes of naïve progenitors as well as erythroid, megakaryocyte and leukocyte-committed
progenitors and we identified CD44, CD326, ICAM2/CD9 and CD18 as novel markers of these progenitors, respectively. Using an artificial neural
network (ANN), that we trained on a scRNAseq derived from human fetal liver, we were able to identify a wide range of hPSCs-derived HPSC
phenotypes, including a small group classified as HSCs. This transient HSC-like population reduced as differentiation proceeded and was
completely missing in the dataset that had been generated using cells selected on the basis of CD43 expression. By comparing the single cell
transcriptome of in vitro-generated HSC-like cells with those generated within the fetal liver we identified transcription factors and molecular
pathways that can be targeted with the aim of improving HSC differentiation in vitro.
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Abstract 24 
Haematopoietic stem and progenitor cells (HSPCs) develop through distinct waves at 25 
various anatomical sites during embryonic development. The in vitro differentiation of 26 
human pluripotent stem cells (hPSCs) is able to recapitulate some of these processes, 27 
however, it has proven difficult to generate functional haematopoietic stem cells (HSCs). 28 
To define the dynamics and heterogeneity of HSPCs that can be generated in vitro from 29 
hPSCs, we exploited single cell RNA sequencing (scRNAseq) in combination with single 30 
cell protein expression analysis. Bioinformatics analyses and functional validation defined 31 
the transcriptomes of naïve progenitors as well as erythroid, megakaryocyte and 32 
leukocyte-committed progenitors and we identified CD44, CD326, ICAM2/CD9 and CD18 33 
2 
as markers of these progenitors, respectively. Using an artificial neural network (ANN), 34 
that we trained on a scRNAseq derived from human fetal liver, we were able to identify a 35 
wide range of hPSCs-derived HPSC phenotypes, including a small group classified as 36 
HSCs. This transient HSC-like population decreased as differentiation proceeded and was 37 
completely missing in the dataset that had been generated using cells selected on the 38 
basis of CD43 expression. By comparing the single cell transcriptome of in vitro-generated 39 
HSC-like cells with those generated within the fetal liver we identified transcription factors 40 
and molecular pathways that can be exploited in the future to improve the in vitro 41 
production of HSCs.  42 
 43 
Introduction 44 
Human pluripotent stem cells (hPSCs) can be differentiated in vitro into various 45 
haematopoietic cell types, providing both a model for basic research studies and a source 46 
of clinically relevant cells1. During embryonic development, two waves of restricted 47 
haematopoietic progenitors arise in the extraembryonic tissues of the yolk sac, before 48 
emergence of haematopoietic stem cells (HSCs) in the embryo proper2. In the mouse 49 
embryo, at E7.25 the first “primitive” wave gives rise to erythrocytes, megakaryocytes and 50 
macrophages3,4, after at E8.25, the second wave, also known as the first “definitive” 51 
progenitors, consists of erythro-myeloid progenitors (EMPs) that can be distinguished from 52 
the primitive progenitors by their potential to generate granulocytes5. Furthermore, the 53 
monocytes that emerge from EMPs provide the embryo with tissue resident macrophage; 54 
the first life-long lasting population of immune cells6–8. Intraembryonic hematopoiesis is 55 
established during E10.5-E11.5 in the aorta-gonad-mesonephros (AGM) region with the 56 
emergence of HSCs, that will sustain the lifespan production of all blood lineages, also 57 
upon transplantation9. A number of studies have indicated that human haematopoietic 58 
development follows a comparable process10–13 but for ethical reasons it has proven 59 
difficult to gain a clear insight into the lineage potential and hierarchical relationships 60 
between early human haematopoietic progenitors. The dynamic nature and the 61 
heterogeneity of haematopoietic progenitor populations that arise during development 62 
poses additional confounders to the identification of molecular mechanisms associated 63 
with their formation and function. 64 
To gain insight into the transcriptome of developing human haematopoietic progenitors, 65 
we performed in-depth characterization of haematopoietic progenitors derived from 66 
3 
hPSCs. Single-cell expression profiles of hPSCs-derived haematopoietic cells have been 67 
reported but these previous studies either used a limited number of cells or used biased 68 
approaches in their isolation and so failed to depict their trajectory of differentiation 14–16. 69 
This significantly impacted on the ability to resolve the complex heterogeneity of the 70 
progenitor pool, to identify the hierarchal relationship between subpopulations and to 71 
compare the transcriptome of hPSCs-derived progenitors to their in vivo counterparts. 72 
To address these issues, we generated scRNAseq data sets of human hPSCs-derived 73 
haematopoietic progenitors. Lineage trajectories predicted in silico were validated by 74 
functional assays of sorted cells and the specificity of our marker repertoire was confirmed 75 
using a CITE-seq17 strategy. Furthermore, to annotate the hPSCs-derived progeny in an 76 
unbiased manner, we employed machine learning and trained an artificial neural network 77 
(ANN) to recognize the single-cell gene expression profiles of human fetal liver cells. This 78 
trained ANN was subsequently used to predict the identities of hPSCs-derived cells. The 79 
ANN thereby provides a mapping between in vivo and in vitro hematopoiesis and revealed 80 
a subset of hPSCs-derived cells that closely resembles HSCs in the foetal liver. Finally, by 81 
comparing that transcriptome of in vitro and in vivo-generated HSCs we identified genetic 82 
pathways that can be exploited to improve HSCs production in vitro from hPSCs.  83 
 84 
Methods 85 




Single cell RNA sequencing of iPSCs-derived haematopoietic progenitor cells 90 
reveals the transcriptome of naïve and lineage committed progenitors. 91 
To resolve the heterogeneity of in vitro generated hPSCs-derived haematopoietic 92 
progenitors we designed a minimal membrane marker strategy that allows to broadly 93 
isolate hPSCs-derived haematopoietic progenitors. This marker strategy was validated 94 
using two hPSC reporter lines, RUNX1C-GFP and KLF1-mCherry, CFU-C assays of 95 
sorted cell populations and gene expression profiling (Supplementary Figure S1). These 96 
data, together with previous reports18–22, supported our rationale that the isolation of 97 
CD235a-CD43+ cells would enrich for HSPCs and exclude cells derived from the primitive 98 
wave (Supplementary Figure S1). We anticipated that the CD235a-CD43+ compartment 99 
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would also comprise the early stages of lineage commitment, capturing the downstream 100 
hierarchy of early human progenitors.  101 
CD235a-CD43+ suspension cells from two independent replicate cultures at day 13 of 102 
differentiation were sorted by FACS and subjected to scRNAseq and data analyses 103 
(Figure 1A). After quality control and clustering23 we obtained the transcriptome of 11420 104 
cells (Supplementary Figure 2A-C) belonging to eight clusters of cells (Figure 1B). 105 
Although the two replicates did not show obvious differences (Supplementary Figure 2C), 106 
any potential batch effect was regressed out prior to integration. We assigned cell 107 
identities based on the expression of known markers and identified additional markers 108 
from the dataset that were cluster specific (Figure 1C-D). Clusters containing more 109 
immature, uncommitted progenitors were identified by their expression of progenitor-110 
associated genes such as KIT and GATA2 and their lack of expression of genes 111 
associated with specific cell lineages and were thus annotated as naïve populations 112 
(Figure 1D, Supplementary Figure 2D). Clusters that displayed expression of lineage 113 
markers were annotated as lineage committed progenitors (Figure 1B-D, Supplementary 114 
Figure 2D), including clusters of cells committed towards the megakaryocyte (GP9 and 115 
PF4), erythroid (GYPA and KLF1) and granulocyte (AZU1 and PRNT3) lineages (Figure 116 
1D). Markers for each of the cell clusters were identified by differential gene expression 117 
analysis, further supporting the identities assigned to each cluster (Figure 1C, 118 
Supplementary Table 1). 119 
 120 
Trajectory analyses reveal the hierarchy of in vitro derived haematopoietic 121 
progenitors. 122 
To study the hierarchical relationship between cell populations, we performed trajectory 123 
analysis using different methods including diffusion analysis24 using Seurat R package23 124 
and pseudotemporal ordering, using Monocle R package25 and Partition-based graph 125 
abstraction (PAGA)26. Diffusion analysis identified a central core from which three distinct 126 
trajectories emerged (Figure 2A). The central core corresponded to cells that we had 127 
annotated as naïve progenitors (Figure 2A-B). Branches comprised cells expressing genes 128 
associated with specific lineages, annotated as Erythroid (Ery)-, Megakaryocyte (Mega)- 129 
and Granulocyte (Granulo)-committed lineages. Comparable trajectories were observed 130 
using pseudotemporal ordering with PAGA and Monocle (Figure 2C-D). The PAGA 131 
analysis showed that the naïve cells were highly connected to erythroid, megakaryocyte 132 
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and granulocyte committed cells (Figure 2C). Pseudotime reconstruction of the hierarchy 133 
showed that cells annotated as naïve 1 were located at the top of the hierarchy and 134 
appeared to progress to naïve 2 cells before entering branches containing lineage 135 
committed cells (Figure 2D-E). Lineage commitment was also inferred from the expression 136 
of lineage-associated transcription factors that were filtered from the cluster specific 137 
marker genes according to their GO annotation (Figure 2F, Supplementary Figure 2E). For 138 
example, erythroid committed clusters demonstrated expression of both KLF1 and MYC, 139 
with the latter decreasing in Ery 2 compared to Ery1, in keeping with their position within 140 
the hierarchy (Figure 2E, F). Within the megakaryocyte-committed clusters 1 and 2 we 141 
observed the expression of GATA1, TAL1 and FLI1 a cocktail of genes recently used for 142 
hPSCs forward programming to megakaryocytes (Figure 2F)27. Granulocyte-committed 143 
cells were represented by a separate branch and demonstrated the expression of CEBP-144 
D, CEBP-B, CEBP-A and CEBP-E (Figure 2F). We then focused our attention on the 145 
transcription factors expressed by the naïve progenitor clusters and noted a high level of 146 
expression of LMO4 and ID2, as well as GATA2 which is known to be expressed in 147 
HSPCs (Figure 2F). We then inferred their role in the gene network using a network 148 
inference algorithm (Partial Information Decomposition and Context, PIDC)28,29. Single cell 149 
transcriptomic data offers the potential to observe dependencies between the expression 150 
profiles of pairs of genes, that if co-regulated, are expected to change in a coordinated 151 
fashion. Genes with highest statistical dependencies are connected by edges that 152 
altogether define the network28,29. Many of the transcription factors previously detected to 153 
be highly expressed within the naïve cell populations such as ID2, ID4 and LMO4, occupy 154 
nodes within this large network (Supplementary Figure 3A-B). This strategy corroborates 155 
the importance of the identified transcription factors as functional elements within the 156 
single cell gene network.  157 
 158 
CD44 membrane expression marks human clonogenic haematopoietic progenitors. 159 
To experimentally validate the results of our trajectory analyses experimentally, we set out 160 
to assess the haematopoietic potential of the naïve progenitor populations. We defined a 161 
prospective sorting strategy using genes encoding the cell surface markers CD33, CD44, 162 
and ITGB2 (also known as CD18) that were enriched within the naïve progenitors’ clusters 163 
(Figure 3A). CD33 was expressed by both naïve 1 and naïve 2 progenitors whereas CD44 164 
and CD18 expression appeared higher in the naïve 1 population (Figure 3A). We 165 
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fractionated CD235a-CD43+CD33+ cells and identified subpopulations as naïve 1A 166 
(CD44+CD18-), naïve 1B (CD44+CD18+) and naïve 2 (CD44-CD18-) (Figure 3B). Trajectory 167 
analysis predicted that naïve 1 cells were at the top of the hierarchy and gave rise to the 168 
naïve 2 cells prior to lineage commitment (Figure 2D-E). To test this in silico prediction, we 169 
used a chimeric co-culture system using the Zeiss Green (ZsG) reporter (Figure 3C). This 170 
approach allowed us to sort, for example, ZsG-labelled naïve 1 cells, then track their ZsG 171 
progeny after being placed back in the complex differentiation environment. We 172 
synchronously differentiated the ZsG-iPSC line, constitutively expressing the fluorescent 173 
reporter30, and the parental iPSC line. To verify the progressions of naïve 1 to naïve 2 and, 174 
naïve 2 to lineage committed cells, we sorted naïve 1 (CD33+CD44-CD18-) or naïve 2 175 
(CD33+CD44+CD18-/+) cells from ZsG-iPSCs at day 10 and co-cultured these with the 176 
synchronized differentiating parental cells for a further 3 days. As predicted from the 177 
trajectory analysis, the naïve 1 cell population was able to generate ZsG-expressing naïve 178 
2 cells. We also noted that the naïve 1 cells retained their immunophenotype, indicating 179 
some self-renewal capacity (Figure 3D). Interestingly, naïve 2 cells demonstrated some 180 
potential to acquire CD44 and CD18, markers of naïve 1 cells (Figure 3D), suggesting 181 
fluidity between these states. As predicted by our trajectory analyses (Figure 2D-E), naïve 182 
2 cells acquired the ability to generate more mature cells including erythroid cells 183 
(CD235a+), megakaryocytes (CD41+) and macrophages (25F9+) (Supplementary Figure 184 
3C). We compared the colony forming capacity of naïve 1 and 2 progenitors present at day 185 
10 and day 13. When plated in clonogenic CFU-C assays, CD44+ naïve 1 cells formed 186 
CFU-C colonies but virtually no colonies were generated by naïve 2 cells at either time 187 
point (Figure 3E-F). These data support the proposed hierarchy and indicate that CD44 188 
expression alone resolves colony forming cells. Our chimeric co-culture system was able 189 
therefore to assess the lineage output that could not be assessed solely by CFU-C assays. 190 
We observed that naïve progenitors expressed high levels of ID genes (Figure 2F), and 191 
that they were identified as nodes within the gene network (Supplementary Figure 3A). As 192 
ID genes are targets of BMP signaling, we predicted that these naïve cells would be 193 
responsive to BMP stimulation. We added BMP4 to differentiation culture from day 10, 194 
when both naïve 1 and 2 were present and then assessed the proportion of these cells 3 195 
days later, In presence of BMP4, we observed a 25% and 59% expansion of naïve 1 and 2 196 
cells respectively (Supplementary Figure 3E). In this experiment we used both hESCs and 197 
hiPSCs and showed that naïve progenitors are present at a comparable frequency in both 198 
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hESCs and hiPSCs (Supplementary Figure 3D), and that naive progenitors derived from 199 
both lines responded to BMP stimulation in a comparable manner (Supplementary Figure 200 
3D-E). Thus this experiment not only identified an important functional signaling pathway 201 
but also confirmed that the markers we used to define naïve progenitors, and their 202 
response to BMP signaling, are not PSC line specific. 203 
To assess whether the naïve cell populations identified using our unique sorting strategy 204 
showed features of definitive haematopoietic progenitors, we assessed the expression of 205 
the RUNX1C-GFP reporter. We observed RUNX1C-GFP expression in both cell types, 206 
with a higher proportion of RUNX1C+ cells in the naïve 1 compared to naïve 2 population 207 
(Figure 3G). Definitive HSPCs are generated via endothelial to hematopoietic transition 208 
(EHT) during embryonic development31,32 so, we would expect comparable hPSCs-derived 209 
progenitors to have hallmarks of their endothelial origin. Here we demonstrate that naïve 210 
CD44+ cells generated in vitro from hPSCs co-expressed CD34 and the endothelial marker 211 
CD144 (also known as VeCad) with expression being higher at day 10, when the majority 212 
of naïve progenitors were present (Supplementary Figure 3L). This endothelial signature of 213 
naïve progenitors, together with their lineage potential reflects their definitive features. To 214 
confirm that CD44 expression was associated with HSPCs in vivo we demonstrated its co-215 
localization with CD45 and CD144 in the mouse yolk sac and AGM region (Supplementary 216 
figure 3F-J). At E10.5 in the yolk sac, CD44 was expressed on endothelial cells in a 217 
bimodal fashion, with vessels expressing low and high levels, the latter being associated 218 
with bright clusters of haematopoietic cells (Supplementary figure 3G). By flow cytometry, 219 
we observed that by E11, all CD45+ cells and a proportion of CD144+ cells were within the 220 
CD44high population (Supplementary figure 3F). Within the embryo proper, CD44 was 221 
expressed on the membrane of endothelial cells within the dorsal aorta, whereas venous 222 
endothelial layers were CD44 negative (Supplementary figure 3H-I). CD44 was also co-223 
expressed with CD45+ in the AGM region (Supplementary figure 3H-J). Furthermore, 224 
expression of LMO4 in CD44+ cells within the AGM region is in keeping with its high level 225 
of expression in naïve hPSCs-derived HSPCs (Figure 2F) and supports its identification as 226 
a novel haematopoietic transcription factor. These data suggest that CD44 is expressed 227 
on haemogenic endothelial cells and it is retained on emerging haematopoietic cells in 228 
vivo, similar to what we have observed during the in vitro differentiation of human 229 
progenitors (Supplementary Figure 3I). 230 
 231 
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Identification of membrane markers of lineage committed progenitors 232 
We next selected membrane markers that we predicted could be used for the isolation of 233 
lineage committed progenitors. Erythroid-primed clusters 1 and 2 both showed expression 234 
of MYC (Figure 2F) and EPCAM (also known as CD326) (Supplementary Figure 4A), 235 
indicative of early committed erythroid cells33,34. We confirmed that CD326 was expressed 236 
in the majority of CD235a+ cells at day 13 of iPSC differentiation but interestingly, we 237 
noted a small number of CD326+CD235a- (Supplementary Figure 4B), suggesting that 238 
CD326 might be marking commitment to the erythroid lineage prior to CD235a acquisition. 239 
To test this, we assessed the expression dynamics of these markers during the erythroid 240 
differentiation of umbilical cord blood CD34+ (UCB34+) cells. At day 10 of differentiation, 241 
CD326 was expressed in CD235a-/low cells but not in CD235ahigh cells, the latter 242 
corresponding to more mature erythroid cells (Supplementary Figure 4B). CD326 was not 243 
expressed in cells at day 18 of the differentiation protocol (when the majority of cells are 244 
mature CD235a+ cells) nor in the mature erythrocytes found in adult peripheral blood 245 
(Supplementary Figure 4B). Taken together these data suggest that CD326 marks early 246 
erythroid progenitors in both hiPSC, fetal and adult derived cells. We also noted the 247 
expression of HBG1, HBG2, HBA1, and HBA2, subunits of fetal hemoglobin, indicative of 248 
erythroid cells derived from definitive hematopoiesis (Supplementary Figure 4C).  249 
Three clusters with megakaryocyte and platelet signatures (Mega-primed 1, 2 and 3) were 250 
predicted by expression of ITGA2B (CD41), GP9, PF4 (Figure 1C-D and Supplementary 251 
Table 1). ICAM2 was expressed at higher level in cluster Mega-primed 3 (Supplementary 252 
Figure 4D), as for CD9, known to increase along megakaryocytes differentiation35. ICAM2 253 
and CD9 co-expression was confirmed by flow cytometry (Supplementary Figure 4D). We 254 
observed a population of CD41+CD9+ICAM2+ cells, with around 85% of the CD41+CD42a+ 255 
(Supplementary Figure 4E), that did not detect polyploidy, supporting their immature status 256 
(Supplementary Figure 4F-G). 257 
Granulocyte-committed clusters were predicted by expression of markers such as MPO, 258 
AZU1, RNASE2 and ITGB2 which encodes the membrane marker CD18, subunit of 259 
different leukocytes marker such as CD11a-d, Mac-1and LFA-1 (Figure 1C, 260 
Supplementary Table 1). We sorted CD235a-CD43+CD33+CD44-CD18+ cells and 261 
confirmed the phenotype of granulocytes and monocytes based on their nuclear 262 
morphology (Supplementary Figure 4H). Further clustering revealed three sub-clusters 263 
corresponding to eosinophil, neutrophils and monocytes lineages (Supplementary Figure 264 
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4I-L). Noteworthy, RUNX3 expression was specifically associated with the monocyte 265 
subcluster (Supplementary Figure 4J) previously reported to be important for zebrafish 266 
stem cells and macrophages36, and to be expressed by mouse tissue resident 267 
macrophages of the skin37. 268 
In summary, we showed that naïve progenitors give rise also to committed progenitors 269 
characterized by features of granulocytes and monocyte, cell types that emerge 270 
exclusively in the definitive waves5.  271 
 272 
CITE-seq analysis of human iPSC-derived haematopoietic progenitors.  273 
To further study the temporal emergence of the progenitor populations and their 274 
associated markers, we carried out CITE-seq analysis whereby single cell membrane 275 
marker expression can be directly correlated with the relative transcriptome17. To ensure 276 
that we sampled even the rarest progenitor cell population we extended the CITE-seq 277 
analysis to adherent cells and included an earlier time point (day 10) in addition to day 13. 278 
Again, to exclude primitive erythroid cells, we selected CD235a-negative suspension cells 279 
but, in this experiment, we included and enriched for CD43- cells that had been excluded 280 
in our initial study. (Supplementary figure 5B). We expected early progenitors to express 281 
CD31 and to potentially remain part of hematopoietic clusters within the adherent fraction 282 
of the culture and so we FAC-sorted the adherent cells into CD31- and CD31+ fractions. 283 
Cells were labeled with oligonucleotide tagged antibody specific for the membrane 284 
markers that we identified in our initial experiment (ADT_CD18, ADT_CD33, ADT_CD41, 285 
ADT_CD44, ADT_CD102, ADT_CD326; ADT: Antibody-Derived Tag) as well as other 286 
markers of endothelial and early committed hematopoietic cells (ADT_CD144) and of 287 
macrophages (ADT_CD163). To test the specificity of the membrane marker repertoire 288 
previously identified on the suspension cells, we subset the two libraries corresponding to 289 
suspension cells collected at day 10 and 13 (Figure 4, Supplementary Figure 5B-C). After 290 
multidimension reduction and clustering analysis we identified a naïve progenitor 291 
population (Figure 4A), comparable to our first sequencing experiment (Figure 2A). These 292 
naïve progenitors exhibited erythroid (Ery), megakaryocyte (Mega), and granulocyte and 293 
monocytes (Gra-Mo) lineage potential, with increased lineage commitment at day 13 294 
compared to day 10 (Figure 4B); in line with the expression pattern of genes associated 295 
with naïve and committed stages in these days (Supplementary Figure 5D). Analysis of the 296 
ADTs showed that each marker was expressed in the expected cluster (Figure 4C) thus 297 
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supporting them as markers for defined progenitors. To further explore the power of the 298 
ADT approach, we performed multidimension reduction using ADTs as the only input 299 
dimensions and proved that ADT data alone identified remarkably similar clusters (Figure 300 
4D-E), strongly correlated with the clusters derived from the entire transcriptome (Figure 301 
4F). Taken together, the CITE-seq approach confirms that the markers identified from our 302 
first scRNAseq analysis define the hierarchy of human developmental hematopoiesis in 303 
vitro with high specificity.  304 
  305 
Comparison of in vitro generated progenitors with in vivo produced cells. 306 
The use of human PSCs as a renewable source of hematopoietic cell types faces major 307 
challenges relating to, for example, the inefficient repopulation capacity of progenitor cells 308 
and the incomplete maturation of differentiated cell types. To identify the underlying 309 
molecular basis associated with these deficiencies in hPSC-derived cells, we compared 310 
our dataset to a human fetal liver dataset which contains the complete hematopoietic 311 
hierarchy from long-term reconstituting HSCs to differentiated cell types.  312 
To assess how hPSCs-derived naïve and lineage-committed progenitors compared to their 313 
equivalent counterpart generated in vivo, we assessed the expression of selected genes 314 
identified to distinguish the various cell types detected in the human fetal liver38 (Figure 315 
4G). An initial analysis of marker genes of lineage commitment in the developing embryo 316 
revealed that these markers are remarkably powerful for discriminating the equivalent in 317 
vitro cell types identified in our in vitro study (Figure 4G, Supplementary Table 1). 318 
Interestingly, SPINK2, a newly reported marker of fetal HSC/MPP38, was also expressed 319 
specifically by our naïve progenitor cells (Figure 4G), together with CD34 (Supplementary 320 
figure 3L). These specific similarities observed between in vitro and in vivo developing 321 
hematopoietic progenitor cells led us to investigate in a more comprehensive manner the 322 
phenotype of cell types that are produced in vitro and how well these in vitro derived cells 323 
reflect the corresponding cell types during in vivo development. Therefore, we used the 324 
same published human fetal liver scRNAseq data as a reference, firstly, to identify in vitro 325 
derived cells with gene expression signatures of human fetal liver hematopoietic cells and, 326 
secondly, to quantify the similarity to their corresponding transcriptomes. To address the 327 
first question, we employed machine learning to transfer labels from the fetal liver 328 
reference data to our in vitro-derived blood cells (Figure 5A). This approach enabled a 329 
much broader and unbiased identification of cell types compared to inference based purely 330 
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on marker genes. We followed our recently developed strategy39 and trained an artificial 331 
neural network (ANN)39 to recognize single-cell gene expression profiles of human foetal 332 
liver cells that were sampled at a time in development at which the liver is the main site of 333 
blood cell formation38. Briefly, this ANN is trained using the expression data of 3,479 334 
genes and 145,725 cells from fetal liver as an input38. From these labelled data, the ANN 335 
learns to predict, from which of the 28 different fetal liver cell types a particular gene 336 
expression pattern originates. Once trained, the ANN is given previously unseen test data 337 
from in vitro derived cells as an input in order to annotate these data with human fetal liver 338 
cell labels. Since this approach considers 3,479 genes, it enabled a more comprehensive 339 
identification of cell types based on similarities in global gene expression patterns rather 340 
than specific marker genes. 341 
The ANN was able to identify cell types within the source domain (the fetal liver data) with 342 
high accuracy as shown by the performance metrics obtained from 5-fold cross-validation 343 
(Supplementary figure 6A-B). The trained ANN was subsequently applied to the target 344 
domain (in vitro) to test if the hPSCs-derived cells were similar to those present in the 345 
foetal liver, in which case the label of that specific in vivo cell would be transferred. The 346 
ANN was able to assign labels to 92% of in vitro produced cells into various cell types 347 
present in vivo (Supplementary figure 6 C-D), most notably, a small population was 348 
labeled as HSC/MPP. This indicates that the global gene expression pattern of a subset of 349 
the in vitro derived cells is very similar to HSC/MPPs from the in vivo reference data in 350 
fetal liver. To quantify precisely how similar these in vitro derived HSC/MPPs are to their in 351 
vivo counterparts, we calculated the average pairwise Euclidean distance between 352 
HSC/MPPs, using the human fetal liver as a reference. This analysis indicates that fetal 353 
liver HSC/MPPs are, on average, only marginally more similar to one another as they are 354 
to iPSC derived HSC/MPPs (Supplementary Figure 8A). In summary, this analysis 355 
indicates that the in vitro derived HSC/MPPs closely, yet not perfectly, reflect the gene 356 
expression patterns of their in vivo counterparts. Using the ANN we also observed that the 357 
relative abundance of the predicted HSC/MPP population decreased with time by day 13 358 
(Figure 5B), whereas, the relative abundance of committed cells increased over this time 359 
as expected (Supplementary Figure 6E). When we applied the same ANN strategy to our 360 
first data set, that was generated from day 13 progenitors that were selected on the basis 361 
of CD43 expression, no HSC/MPP were detected (Figure 5C). This is consistent with our 362 
observation that this transient HSC/MPP population is present in higher numbers earlier at 363 
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day 10, when they are almost equally distributed in the adherent CD31+ and suspension 364 
CD235a- compartment (Supplementary Figure 6F). We looked for marker genes that 365 
defines this predicted HSC/MPP cell population in vitro and looked specifically for 366 
membrane markers according to their GO annotation (Supplementary Table 1). Together 367 
with expected markers such as CD34, CD44 and CD33, we also detected CD132, CD52, 368 
CD180 and IL3RA and many others that will allow to design a prospective sorting strategy 369 
to isolate this specific population. We then subset the in vivo and in vitro HSC/MPP and 370 
integrated the two datasets (Figure 5D). The integrated data allowed for direct comparison 371 
of their transcriptome and identified 54 differentially expressed genes (Supplementary 372 
Table 1), all of which were lower in HSC/MPP produced in vitro compared to those 373 
generated in vivo. GO analysis of these genes identified enrichment for KEGG signaling 374 
pathways such as NOD-like receptor, IL-17, NF-Kappa B and HIF-1 (Supplementary Table 375 
1). We also identified 6 genes encoding transcription factors: EGR1, ZFP36L1, NR4A1, 376 
FOS, JUN and JUNB (Figure 5E). Interestingly, the EGR1 binding site was enriched, 377 
amongst others, in the upstream region of the differentially expressed genes (Figure 5F), 378 
suggesting an important regulatory role of EGR1.  379 
We also compared the predicted HSC/MPP derived from hPSCs to hematopoietic 380 
progenitors isolated from different sited of hematopoiesis in the developing embryo 381 
including to fetal liver HSC/MPP38, yolk sac MPP38 that were collected at Carnegie stages 382 
5 to 14, and AGM40 sorted progenitors (CD34+CD45+CD235a-) collected at Carnegie 383 
stage 15, around the time of early HSC emergence (Supplementary Figure 7A-B). Whole 384 
transcriptome comparison, followed by KEGG pathway analysis, showed that in vitro 385 
HSC/MPP cells are marked by genes associated with oxidative phosphorylation 386 
(Supplementary Table 1), indicating metabolic differences between in vitro and in vivo 387 
produced progenitors. Hypoxic conditions characterize mammalian embryo 388 
develepoment41, and more specifically the development of the hematopoietic system, 389 
where hypoxia has been detected in hematopoietic clusters in the AGM region, and in the 390 
fetal liver 42. The hematopoietic progenitors derived from hPSCs were instead 391 
differentiated in normoxic conditions which could explain their different metabolic profile. 392 
The fetal liver cells were marked by HLA genes and consequently KEGG pathways 393 
associated with antigen presentation and T-cell development (Supplementary Table 1). 394 
The AGM dataset displayed high expression levels of genes associated with Notch 395 
pathway, such as HES1, NOTCH1, NOTCH2, JAG1 and JAG2. This is in line with the 396 
13 
developmental stage at which they were collected when the Notch pathway is 397 
orchestrating the HSC emerge43. Within the markers of yolk sac progenitors, we detected 398 
genes related to early hematopoietic development. FRZB, mesodermal cell marker, and 399 
HBE1, marker of primitive hematopoiesis, were listed in the top 10 differentially expressed 400 
genes: this underlines the early developmental features of yolk sac progenitors. Finally, we 401 
noted also that SPINK1 was identified as marker for YS progenitors. While SPINK2, 402 
identified here and by others as marker of progenitor cells38,40 was expressed by 403 
progenitors from all the tissues, SPINK1 was detected exclusively in the YS 404 
(Supplementary Figure 7X), suggesting that this gene could discriminate extraembryonic 405 
from intraembryonic hematopoiesis.  406 
Finally, we compared lineage committed cells identified by the ANN, in our in vitro dataset, 407 
to their in vivo counterpart from fetal liver, to identify genes that can be used as targets to 408 
improve the production in vitro of differentiated blood cell types. We listed the differentially 409 
expressed genes between in vitro and fetal liver cells and identified the transcription 410 
factors within the list (Supplementary Figure 8, Supplementary Table 1). Particularly 411 
interesting, late erythroid cells in vitro show high level of PCLG2, phospholipase C gamma 412 
2, able to control intracellular calcium via production of IP3, inositol triphosphate. 413 
Intracellular calcium peaks just before enucleation, prior nuclei extrusion in the  414 
orthochromatic erythroblasts44. Erythroid cells derived from hPSCs are characterized by a 415 
general inefficient enucleation45,46, independently or their primitive or definitive origin 416 
(Supplementary Figure 1J) and this could be related to their intracellular calcium control.    417 
In summary, we have identified a rare population of HSC/MPP-like cells in vitro that 418 
emerge early during differentiation of hPSCs and that display broadly similar gene 419 
expression patterns when compared to HSCs in development. However subtle differences 420 
are also apparent and a more detailed study of these differences could explain the known 421 
deficiencies of PSC-derived cells and ultimately be exploited to improve their therapeutic 422 
use. Our novel approach combines scRNAseq and machine learning to help identify 423 
candidate genes that may improve the production of HSCs and mature lineage cells from 424 






We described the single cell transcriptome and membrane markers of naïve hematopoietic 430 
progenitors and their lineage committed descendants derived in vitro from human 431 
pluripotent stem cells. The repertoire of membrane markers proved to be remarkably 432 
accurate in capturing the different states prior to and after lineage commitment. 433 
We identified a population of naïve progenitors situated at the top of the differentiation 434 
hierarchy, marked by CD44, a protein involved in the hematopoietic transition of the 435 
hemogenic endothelium in the mouse AGM region47. We validated their lineage potential 436 
employing a chimeric culture system, where isolated naïve progenitors, marked by Zeiss-437 
Green expression, demonstrated overlapping lineage output to that predicted in silico. 438 
We also observed that progenitors are capable of moving between the naïve states, as 439 
well as progressing into committed states. This is in keeping with many other scRNAseq 440 
and proteomic studies that have reported a continuum of cell states as opposed to 441 
sequential discrete cell types hierarchies48–51. In line with a recent murine study47, we have 442 
shown that CD44 is expressed in naïve hPSCs-derived progenitors and here we 443 
demonstrated that both human and mouse progenitors also express LMO4, a LIM-domain 444 
protein52. Recent scRNAseq detected LMO4 in both human granulocyte progenitors in the 445 
bone marrow48 and adult mouse HSC53, but its associated proteins have not been 446 
identified. We also reported high levels of ID genes within the progenitors, target genes of 447 
BMP signaling known to be involved in HSC emergence54–56. IDs, like LMOs proteins, do 448 
not present DNA binding domain and rather act through binding of other proteins in 449 
complexes also involved in HSPC development57 and erythropoiesis58 . Overexpression of 450 
ID2 in human HSC from cord blood has been reported to enhance their functional 451 
stemness in vivo59, supporting the idea that this class of proteins might maintain the 452 
progenitor status and thus might be useful in alternative programming strategies of hPSCs.   453 
The use of scRNAseq on vast numbers of cells allows to detect even the rarest cell 454 
population and we considered that it might enable the detection of rare HSC-like cells in 455 
differentiating hPSCs cultures. We showed to hPSCs-derived cells showed a remarkable 456 
specific expression pattern of marker genes identified in the human embryo, for example, 457 
SPINK2, a novel marker of human fetal liver HSC and MPP, marked also our naïve 458 
progenitors. By using machine learning we identify specific cell types sampled in vivo and 459 
detected a small and transient population of HSC-like cells that, when compared to their in 460 
vivo counterpart from fetal liver, showed only small transcriptional differences. Previous 461 
reports described the hematopoietic progenitors obtained with the differentiation employed 462 
15 
in this work as intraembryonic-like18, using T-cells lineage as hallmark of definitive 463 
hematopoiesis. However, yolk sac shows T-cell potential prior to HSC emergence60,61, 464 
thus limiting the use of T-cell assay alone as discriminative of the corresponding 465 
developmental wave. Our machine learning approach and the detection of HSC-like cells 466 
strongly supports the intraembryonic identities of the hematopoietic cells differentiated in 467 
vitro and provide an alternative and multifactorial approach to address questions regarding 468 
the similarities to developmental counterparts. The unbiased and comprehensive 469 
comparison used in this study allowed us to pinpoint differentially expressed genes 470 
between in vitro-derived and in vivo HSCs can now be exploited to improve production of 471 
HSC in vitro. Our analysis indicates in vitro HSC-like cells do not express CD43, 472 
comparable to mouse Pro-HSC prior their maturation into functional definitive HSC62. This 473 
could suggest that the widely acknowledged inability of hPSCs-derived progenitors to 474 
reconstitute the hematopoietic system, could be due to their immature phenotype and the 475 
lack of appropriate culture conditions for HSCs maturation and maintenance. In addition, 476 
the identification of the HSC-like population using our machine learning approach, which is 477 
based on high similarity in the gene expression profiles, could suggest that the molecular 478 
basis of the functional deficiency of this in vitro derived population could reside at a post-479 
transcriptional level. Thus, future experiment will be required to assess whether a further 480 
ad-hoc maturation step of sorted HSC-like cells would achieve reconstitution.  481 
When we compared the hematopoietic progenitors developed in the human embryo 482 
throughout gestations together with those derived in vitro, we found that while SPINK2 483 
was expressed by all progenitors, SPINK1 was exclusively detected in cells from the yolk 484 
sac. SPINK1 is able to bind to EGFR and induce epithelial to mesenchymal transition in 485 
cancer cells63,64, a process similar to the endothelial to hematopoietic transition, where the 486 
role of SPINK1 remains largely unexplored. In summary, we propose here SPINK1 as a 487 
possible marker for primitive hematopoiesis which could be an extremely useful genes to 488 
trace the cells that colonize the embryo from the yolk sac.  489 
The differentiation protocol used in this study is well defined and serum-free and is one of 490 
the most commonly used protocols used by many laboratories. We also showed that our 491 
markers are able to identify functionally similar progenitors in different cell lines. Thus, our 492 
browsable datasets and the findings of our study will be of interest to many in the field of 493 
hematopoiesis and will allow to test how the frequency of this populations vary in response 494 
to different cytokines conditions. In addition, the increasing availability of large scRNAseq 495 
16 
dataset of human tissue makes our pipeline applicable to the analyses of other systems 496 
where the hPSCs differentiation aims to produce adult-like cells for clinical application. In 497 
this way cell types differentiated in vitro can now be annotated in an unbiased manner that 498 
does not rely on few known markers and allows the identification of transcriptional 499 
discrepancies between cell types produced in vitro and their in vivo counterparts. 500 
In conclusion, our browsable dataset provides a comprehensive transcriptional 501 
characterization of in vitro derived hematopoietic progenitors. This work defines the 502 
makeup of the progenitor populations that give rise to immune cells, such as macrophages 503 
and granulocytes, as well as HSC-like cells, which holds great promise for their 504 
therapeutically application.  505 
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Figure Legends 700 
 701 
Figure 1 - Single cell transcriptome analysis reveals clusters of naïve and lineage-702 
committed haematopoietic progenitors. 703 
(A) Schematic of the single cell RNA sequencing experiment where iPSCs (SFCi55) were 704 
differentiated in vitro (IVD) for 13 days (Supplementary Figure1A), CD235a-CD43+ 705 
suspension cells were isolated by flow cytometry and subjected to 10x genomics 706 
sequencing platform. (B) tSNE visualization of 11,420 cells divided into 8 clusters including 707 
clusters defined by gene expression as naïve (naïve 1 and 2), and others that expressed 708 
genes associated with erythroid (Ery1 and 2), megakaryocyte (Mega 1,2 and 3) and 709 
granulocyte (granulo) lineages. (C) Heatmap showing expression of the top 10 marker 710 
genes for each cluster (colors for each cluster as in Figure 1B). (D) Gene expression 711 
levels of marker genes associated with different progenitor cell types that were identified 712 
by clustering, visualized on tSNE. 713 
 714 
Figure 2 - Trajectory analyses support naïve progenitor identity and their 715 
progression to lineage committed progenitors.  716 
(A) Diffusion plot displays the naïve progenitors in the core region of the plot from where 717 
the three direction of commitment originates, the arrows indicates the commitment 718 
directions. (B) Representation of each cluster on the diffusion plot. (C) PAGA analysis 719 
show that naïve cluster are connected to the lineage committed cells. Each node contains 720 
21 
a pie chart showing the proportion of cells for each cluster. Colors indicate cluster 721 
identities. (D) Monocle trajectory analyses demonstrates a similar pattern to that obtained 722 
from the diffusion plot shown in A with naïve progenitors at the top of the hierarchy, with 723 
progression toward committed. (E) Monocle trajectory visualizing each cluster 724 
individually. (F) Expression levels of the marker genes coding for transcription factors 725 
associated with each cluster, bars color indicates the cluster. 726 
 727 
Figure 3 - CD44 identifies clonogenic hematopoietic progenitors. 728 
(A) Expression levels of genes encoding cell surface markers, CD33, CD44 and CD18 that 729 
were associated with the naïve progenitor clusters. (B) Scatter plot of flow cytometry 730 
profile of naïve 1A, 1B and 2 cells at day 13 of differentiation (hiPSCs-SFCi55). Cells are 731 
gated on CD235a-CD43+CD33+. (C) Schematic of the chimeric culture system using the 732 
ZsGreen reporter to trace cells during the differentiation process. ZsGreen and parental 733 
line (SFCi55) were differentiated in a synchronous manner, at day 10 naïve 1 and naïve 2 734 
cells are sorted and co-cultured with the parental line differentiation. Co-culture is then 735 
analyzed at day 13. (D) Representative flow cytometry profile of the day 13 naïve 736 
descendants’ cells after sorting at day 10 and chimeric co-culturing of naïve 1 (teal) and 737 
naïve 2 (pink) cells. Contribution of naïve 1, in teal, and naïve 2, in pink, to the naïve 1A, 738 
1B and 2 compartment (n=6, multinomial logistic regression, *p<0.05, **p<0.01, 739 
***p<0.005). (E) CFU-C analyses of FAC-sorted naïve 1 and naïve 2 cells from day 10 740 
(n=3, paired t-Test p=0.0753) (hiPSCs-SFCi55). (F) CFU-C analyses of FAC-sorted naïve 741 
1A, 1B and 2 cells from day 13 (n=9, Holm-Sidak’s test, p<=0.001) (hiPSCs-SFCi55). (G) 742 
RUNX1-GFP expression in naïve 1 and naïve 2 at both day 10 and day 13 (n=12, paired t 743 
test; * p<0.05, ** p<0.01). 744 
 745 
Figure 4 - CITE-seq analyses confirm markers for naïve and lineage-committed 746 
progenitor cells. 747 
(A) tSNE visualization of the CITE-seq analysis of day 10 and day 13 CD235a- suspension 748 
cells; reduction and clustering were performed using only transcriptomic data (hiPSC-749 
SFCi55). (B) tSNE visualization of the libraries obtained from CD235a- suspension cells 750 
collected at day 10 (pink) and day 13 (teal) showing lineage commitment direction. (C) 751 
Single cell protein expression level of the membrane markers associated with the different 752 
cell types. Data are visualized on tSNE (ADT = antibody derived tags). (D) tSNE plot and 753 
annotation of clustering obtained from analysis derived from ADT data alone. (E) 754 
Visualization of the libraries obtained from CD235a- suspension cells projected on the 755 
tSNE obtained from ADT data in D, cell progression shows lineage commitment trajectory. 756 
Cells are colored according to the day of collection (day 10 in pink and day 13 in teal). (F) 757 
Confusion matrix of clustering obtained from complete transcriptomic data (RNA) and that 758 
obtained from ADT data alone. Color of each box indicates the % of cells classified in each 759 
RNA versus ADT cluster. (G) Gene expression levels of human foetal gene marker genes 760 
in our naïve and lineage committed progenitors. 761 
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Figure 5 - Artificial neural network identifies HSC-like cells in iPSC derived 763 
hematopoietic cells.  764 
((A) Schematic of the artificial neural network (ANN) architecture for label-transfer. An 765 
input layer (3479 units), two fully connected hidden layers (64 and 32 units) and a 28-unit 766 
softmax layer corresponding to cell types in the source domain (human foetal liver 767 
scRNAseq data) used for training. Classification of cell types in the target domain of 768 
human iPSC-derived single cell transcriptomes (test data). (B) Proportion of cells labelled 769 
HSC/MPPs at day 10 or day 13 of hiPSC differentiation in vitro. (C) Proportion of in vitro 770 
derived CD235a- progenitors and CD235a-CD43+ cells labelled HSC/MPP by the ANN (ND 771 
= not detected). (D) UMAP visualization of the integrated dataset containing in vivo derived 772 
(blue) and in vitro annotated (pink) HSC/MPPs. (E) Heatmap of differentially expressed 773 
genes coding for transcription factors obtained from the comparison of in vivo and in vitro 774 
derived HSC/MPPs. (F) Transcription factor binding motifs enriched upstream of the 54 775 
genes identified as differentially expressed between HSC/MPP generated in vitro and in 776 
vivo.  777 
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